Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis
Copyright © 2018 Elsevier Inc. All rights reserved..
The tolerogenic microenvironment of the liver is associated with impaired hepatic T cell function. Here, we examined the contribution of liver-resident natural killer (LrNK) cells, a prominent hepatic NK cell compartment, to T cell antiviral responses in the liver. The number of virus-specific T cells increased in LrNK-cell-deficient mice during both acute and chronic lymphocytic choriomeningitis virus infection. Upon infection with adenovirus, hepatic T cells from these mice produced more cytokines, which was accompanied by reduced viral loads. Transfer of LrNK cells into LrNK-cell-deficient or wild-type mice inhibited hepatic T cell function, resulting in impaired viral clearance, whereas transfer of conventional NK cells promoted T cell antiviral responses. LrNK-cell-mediated inhibition of T cell function was dependent on the PD-1-PD-L1 axis. Our findings reveal a role for LrNK cells in the regulation of T cell immunity and provide insight into the mechanisms of immune tolerance in the liver.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
---|---|
Enthalten in: |
Immunity - 50(2019), 2 vom: 19. Feb., Seite 403-417.e4 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhou, Jing [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 13.08.2019 Date Revised 13.08.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.immuni.2018.12.024 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM293365652 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM293365652 | ||
003 | DE-627 | ||
005 | 20231225075146.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.immuni.2018.12.024 |2 doi | |
028 | 5 | 2 | |a pubmed24n0977.xml |
035 | |a (DE-627)NLM293365652 | ||
035 | |a (NLM)30709740 | ||
035 | |a (PII)S1074-7613(18)30572-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhou, Jing |e verfasserin |4 aut | |
245 | 1 | 0 | |a Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.08.2019 | ||
500 | |a Date Revised 13.08.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2018 Elsevier Inc. All rights reserved. | ||
520 | |a The tolerogenic microenvironment of the liver is associated with impaired hepatic T cell function. Here, we examined the contribution of liver-resident natural killer (LrNK) cells, a prominent hepatic NK cell compartment, to T cell antiviral responses in the liver. The number of virus-specific T cells increased in LrNK-cell-deficient mice during both acute and chronic lymphocytic choriomeningitis virus infection. Upon infection with adenovirus, hepatic T cells from these mice produced more cytokines, which was accompanied by reduced viral loads. Transfer of LrNK cells into LrNK-cell-deficient or wild-type mice inhibited hepatic T cell function, resulting in impaired viral clearance, whereas transfer of conventional NK cells promoted T cell antiviral responses. LrNK-cell-mediated inhibition of T cell function was dependent on the PD-1-PD-L1 axis. Our findings reveal a role for LrNK cells in the regulation of T cell immunity and provide insight into the mechanisms of immune tolerance in the liver | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a PD-L1 | |
650 | 4 | |a antiviral responses | |
650 | 4 | |a conventional NK cells | |
650 | 4 | |a hepatic T cells | |
650 | 4 | |a liver-resident NK cells | |
650 | 7 | |a B7-H1 Antigen |2 NLM | |
650 | 7 | |a Cd274 protein, mouse |2 NLM | |
650 | 7 | |a Programmed Cell Death 1 Receptor |2 NLM | |
700 | 1 | |a Peng, Hui |e verfasserin |4 aut | |
700 | 1 | |a Li, Kun |e verfasserin |4 aut | |
700 | 1 | |a Qu, Kun |e verfasserin |4 aut | |
700 | 1 | |a Wang, Baohui |e verfasserin |4 aut | |
700 | 1 | |a Wu, Yuzhang |e verfasserin |4 aut | |
700 | 1 | |a Ye, Lilin |e verfasserin |4 aut | |
700 | 1 | |a Dong, Zhongjun |e verfasserin |4 aut | |
700 | 1 | |a Wei, Haiming |e verfasserin |4 aut | |
700 | 1 | |a Sun, Rui |e verfasserin |4 aut | |
700 | 1 | |a Tian, Zhigang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Immunity |d 1994 |g 50(2019), 2 vom: 19. Feb., Seite 403-417.e4 |w (DE-627)NLM075097818 |x 1097-4180 |7 nnns |
773 | 1 | 8 | |g volume:50 |g year:2019 |g number:2 |g day:19 |g month:02 |g pages:403-417.e4 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.immuni.2018.12.024 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 50 |j 2019 |e 2 |b 19 |c 02 |h 403-417.e4 |